Results 191 to 200 of about 546,706 (238)

Unmasking Mucopolysaccharidosis Type I in a Patient With Wolf–Hirschhorn Syndrome: Diagnostic Overshadowing

open access: yesJIMD Reports, Volume 67, Issue 5, September 2026.
ABSTRACT Mucopolysaccharidosis Type I (MPS I) is a rare lysosomal storage disorder caused by α‐l‐iduronidase deficiency, leading to glycosaminoglycan accumulation and multisystem involvement. Wolf–Hirschhorn Syndrome (WHS) is a chromosomal disorder characterized by growth delay, dysmorphism, and developmental impairment.
Karla Cifuentes‐Uribe   +4 more
wiley   +1 more source

Clinical Manifestations Associated With RT‐PCR–Confirmed Zika Virus Infection Among Adults With Acute Rash in the Brazilian Amazon: A Cross‐Sectional Study

open access: yesJournal of Medical Virology, Volume 98, Issue 9, September 2026.
ABSTRACT Zika virus (ZIKV) infection remains a diagnostic challenge in regions where multiple arboviruses co‐circulate, particularly when laboratory testing is limited. Identifying distinguishing clinical features is therefore relevant for early case recognition. We conducted a cross‐sectional study including 1124 adults presenting with acute exanthema
Djane Clarys Baía‐da‐Silva   +8 more
wiley   +1 more source

Admission‐Time Clinicolaboratory Phenotypes for Early Differentiation of Severe Fever With Thrombocytopenia Syndrome and Hemorrhagic Fever With Renal Syndrome

open access: yesJournal of Medical Virology, Volume 98, Issue 9, September 2026.
ABSTRACT Early differentiation of severe fever with thrombocytopenia syndrome (SFTS) and hemorrhagic fever with renal syndrome (HFRS) remains difficult in endemic settings. In this single‐center retrospective comparative study, we analyzed admission‐time demographic, clinical, and laboratory data from 330 hospitalized patients with laboratory‐confirmed
Ruize Ma   +7 more
wiley   +1 more source

Differentiation Syndrome and Sweet Syndrome‐Like Overlap Following Venetoclax–Azacytidine and G‐CSF Therapy

open access: yesJEADV Clinical Practice, Volume 5, Issue 3, Page 967-970, September 2026.
ABSTRACT Differentiation syndrome (DS) and Sweet syndrome (SS) are inflammatory complications mediated by cytokine dysregulation, classically associated with therapies that promote myeloid differentiation or cytokine release. While DS has been primarily linked to all‐trans retinoic acid (ATRA) and IDH inhibitors, recent evidence suggests that ...
Katerina Grafanaki   +6 more
wiley   +1 more source

Washed Microbiota Transplantation Improves Chronic‐Phase Febrile Infection‐Related Epilepsy Syndrome: The First Case Report With Long‐Term Follow‐Up and Integrated Multi‐Omics Analysis

open access: yesMicrobiota Medicine Research, Volume 1, Issue 3, Page 107-115, September 2026.
ABSTRACT Background Febrile infection‐related epilepsy syndrome (FIRES) is a catastrophic epileptic encephalopathy. Survivors often enter a chronic phase characterized by drug‐resistant epilepsy, cognitive impairment, behavioral and psychiatric symptoms, and long‐term functional disability.
Qianqian Li   +3 more
wiley   +1 more source

Clobazam and Valproate, but Lamotrigine, a Sodium Channel Inhibitor, Reduce the Incidence of Hyperthermia‐Induced Clonic Seizures in Dravet Syndrome Mice: Assessment of Anti‐Seizure Effects in Mice Using a Stabilized Ambient Temperature System

open access: yesNeuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.
Using a stabilized incubator‐based hyperthermia model of Dravet syndrome, we showed that clobazam and valproate significantly reduced heat‐induced clonic seizures and delayed seizure onset in Scn1a KI/+ mice. In contrast, lamotrigine showed no protective effect.
Futa Sato   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy